Delivery Order SPE2DB24D1201-SPE2DB25FJEBG
- Not listed
- The Defense Logistics Agency awarded a $11,574.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors, with an ultimate completion date of August 26, 2025. This non-set-aside competitive award was issued on August 25, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $9,253.56 to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors, with an ultimate completion date of August 29, 2025. This competitive award, issued on August 28, 2025, carries firm fixed pricing and involves no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded a $34,601.94 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of ENBREL 50 mg/mL SureClick auto-injector pharmaceutical product. The delivery order, which carries an ultimate completion date of August 25, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026....
- The Defense Logistics Agency awarded a $122,324.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENBREL 50 MG/ML SureClick auto-injector pharmaceutical products, with an ultimate completion date of July 29, 2025. This non-set-aside competitive award was issued on July 28, 2025, for delivery to the company's corporate office location in Conshohocken, Pennsylvania. The delivery order is executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $10,418.36 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of ENBREL 50 mg/ml SureClick auto-injectors. This competitively awarded, firm fixed-price contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a $39,049.72 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Enbrel 50 mg/mL SureClick auto-injectors. This competitively awarded, firm fixed-price contract serves as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical will be delivered to AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $16,485.88 firm fixed price delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/ml SureClick auto-injector pharmaceutical products on August 11, 2025, with an ultimate completion date of August 12, 2025. The contract is unclassified and carries no set-aside designation, indicating it was competitively awarded. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents...
- The Defense Logistics Agency awarded a $35,026.70 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of ENBREL 50 MG/ML SureClick auto-injectors. The contract, which carries a completion date of July 28, 2025, was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform work at its corporate office location. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $9,422.26 to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injectors. The contract, awarded on August 21, 2025, with an ultimate completion date of August 22, 2025, represents a firm fixed price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order through its corporate office operations. This...
- The Defense Logistics Agency awarded a $21,861.17 delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injectors on August 11, 2025, with completion targeted for August 12, 2025. This competitively awarded, firm fixed-price delivery order represents a routine pharmaceutical procurement supporting federal medical supply needs. The contract is performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, where the company maintains operations as...
- SPE2DB24D1201Indefinite Delivery Contract
- SPE2DB24D1201-SPE2DB25FJEBGDelivery Order
The Defense Logistics Agency awarded a $65,024.56 firm fixed price delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/ml SureClick autoinjector pharmaceutical supplies on September 2, 2025, with an ultimate completion date of September 3, 2025. The contract involves no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a total value of $999,999,999.00 through December 2026 and serves as a comprehensive global pharmaceutical support vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills critical federal medical procurement needs primarily for military and veteran healthcare systems. The company's portfolio under the DLA contract encompasses a wide range of pharmaceutical products and medical supplies including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This delivery order for ENBREL, a biologic used to treat inflammatory conditions, represents one of numerous competitively awarded transactions the contractor executes through the prime IDC vehicle, demonstrating its capability to meet federal procurement requirements across diverse military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $65.0k | 9/2/25 |